浏览全部资源
扫码关注微信
1.北京中医药大学 中药品质评价北京市重点实验室,北京 102488
2.北京中医药大学 中医学院,北京 100029
3.中国食品药品检定研究院,北京 102629
陈林珍,在读硕士,从事中药药效物质基础研究,E-mail:chenlinzhen123@126.com
马志强,博士,研究员,从事中药药效物质基础研究,E-mail:mazq1968@sina.com; *
赵崇军,博士,助理研究员,从事中药安全性评价及主要活性/毒性物质基础筛选,E-mail:1014256537@qq.com
纸质出版日期:2023-11-20,
网络出版日期:2023-07-28,
收稿日期:2023-06-08,
扫 描 看 全 文
陈林珍,张雪,陈祺等.基于斑马鱼模型与网络药理学研究苦参碱治疗炎症性肠病的作用机制[J].中国实验方剂学杂志,2023,29(22):88-94.
CHEN Linzhen,ZHANG Xue,CHEN Qi,et al.Study on Mechanism of Action of Matrine in Treatment of Inflammatory Bowel Disease Based on Zebrafish Model and Network Pharmacology[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(22):88-94.
陈林珍,张雪,陈祺等.基于斑马鱼模型与网络药理学研究苦参碱治疗炎症性肠病的作用机制[J].中国实验方剂学杂志,2023,29(22):88-94. DOI: 10.13422/j.cnki.syfjx.20230914.
CHEN Linzhen,ZHANG Xue,CHEN Qi,et al.Study on Mechanism of Action of Matrine in Treatment of Inflammatory Bowel Disease Based on Zebrafish Model and Network Pharmacology[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(22):88-94. DOI: 10.13422/j.cnki.syfjx.20230914.
目的
2
基于斑马鱼模型与网络药理学技术研究苦参碱治疗炎症性肠病(IBD)的作用机制。
方法
2
以2,4,6-三硝基苯磺酸(TNBS)建立斑马鱼IBD模型,使用中性红染色、阿尔新蓝染色及中性粒细胞数量变化评估肠道吞噬功能、杯状细胞分泌及中性粒细胞聚集情况,利用相关试剂盒测定苦参碱(40、60 mg·L
-1
)对斑马鱼体内肿瘤坏死因子(TNF)-
α
与胆囊收缩素(CCK)含量变化;使用网络药理学及分子对接技术预测苦参碱治疗IBD的潜在作用机制;并通过实时荧光定量聚合酶链式反应(Real-time PCR)对相关靶点验证基因表达情况。
结果
2
与模型组比较,苦参碱组能够呈剂量依赖性增加中性红染色面积(
P
<
0.05,
P
<
0.01),改善肠道吞噬功能;能够增加阿尔新蓝染色面积(
P
<
0.05,
P
<
0.01),影响肠道杯状细胞分泌;能够减少中性粒细胞数量(
P
<
0.01)及缓解其聚集情况,显著减少TNF-
α
含量(
P
<
0.01);苦参高剂量组显著增加CCK含量(
P
<
0.01),苦参低剂量组CCK含量差异无统计学意义。网络药理学分析得到苦参碱治疗IBD潜在靶点28个,蛋白质-蛋白质相互作用(PPI)网络分析得度值排名前5的靶点分别为
α
7烟碱乙酰胆碱受体(CHRNA7)、多巴胺受体D1(DRD1)、烟碱型乙酰胆碱
α
4亚型(CHRNA4)、溶质载体家族6成员3(SLC6A3)、代谢型谷氨酸受体5(GRM5);京都基因与基因组百科全书(KEGG)结果显示,苦参碱治疗IBD可能与神经活性配体-受体相互作用(neuroactive ligand-receptor interaction)、胆碱能突触(cholinergic synapse)、中性粒细胞胞外诱捕网形成(neutrophil extracellular trap formation)相关,且Real-time PCR结果表明苦参碱能够影响相关靶点基因表达水平。
结论
2
苦参碱对炎症性肠病具有一定的治疗作用,能够影响IBD炎症反应,其治疗作用可能与神经活性配体-受体相互作用等通路相关。
Objective
2
To study the mechanism of matrine in the treatment of inflammatory bowel disease (IBD) based on the zebrafish model and network pharmacology.
Method
2
The IBD model of zebrafish was established using 2,4,6-trinitro-benzenesulfonicacid (TNBS), and the intestinal phagocytic function, goblet cell secretion, and neutrophil aggregation were evaluated using neutral red staining, alcian blue staining, and neutrophil number changes. Changes in tumor necrosis factor (TNF)-
α
and cholecystokinin (CCK) content in zebrafish were determined by using relevant reagent kits. Network pharmacology and molecular docking techniques were used to predict the potential mechanism of matrine in the treatment of IBD. Gene expression of relevant targets was verified through Real-time polymerase chain reaction (Real-time PCR).
Result
2
Compared with the model group, the matrine administration group can increase the neutral red staining area in a dose-dependent manner and improve intestinal phagocytic function(
P
<
0.05,
P
<
0.01). It can reduce the staining area of alcian blue and affect the secretion of intestinal goblet cells(
P
<
0.01). It can reduce the number of neutrophil granulocytes, relieve its aggregation, significantly reduce TNF-
α
content(
P
<
0.01), and increase the CCK content. Network pharmacology analysis identifies 28 potential targets for matrine in the treatment of IBD. The top five targets by protein-protein interaction (PPI) network analysis are CHRNA7, DRD1, CHRNA4, SLC6A3, and GRM5. The Kyoto encyclopedia of genes and genomes (KEGG) results show that the treatment of IBD with matrine may be related to neuroactive ligand-receptor interaction, cholinergic synapse, and neutrophil extracellular trap formation. Real-time PCR results show that matrine can affect the expression level of related target genes.
Conclusion
2
matrine has a certain therapeutic effect on IBD and can affect the inflammatory response of IBD. Its therapeutic effect may be related to neuroactive ligand-receptor interaction and other pathways.
苦参碱炎症性肠病斑马鱼网络药理学作用机制
matrineinflammatory bowel diseasezebrafishnetwork pharmacologymechanism
GUAN Q.A comprehensive review and update on the pathogenesis of inflammatory bowel disease[J].J Immunol Res,2019,2019:7247238.
钱家鸣,杨红.中国炎症性肠病研究的历史回顾现状和展望[J].中国实用内科杂志,2015,35(9):727-730.
李芝奇,徐玥,赵霞,等.斑马鱼作为一种重要的工具进行肝脏疾病研究[J].中国中药杂志,2021(2):320-332.
OH S Y,CHO K A,KANG J L,et al.Comparison of experimental mouse models of inflammatory bowel disease[J].Int J Mol Med,2014,33(2):333-340.
FLEMING A,JANKOWSKI J,GOLDSMITH P.In vivo analysis of gut function and disease changes in a zebrafish larvae model of inflammatory bowel disease: A feasibility study[J].Inflamm Bowel Dis,2010,16(7):1162-1172.
OEHLERS S H,FLORES M V,HALL C J,et al.Chemically induced intestinal damage models in zebrafish larvae[J].Zebrafish,2013,10(2):184-193.
林丹,许少华.复方苦参汤治疗慢性溃疡性结肠炎的临床疗效及对炎症因子的影响[J].慢性病学杂志,2019,20(7):1044-1046.
李智,黄忠.苦参片联合美沙拉嗪肠溶片治疗溃疡性结肠炎的临床研究[J].现代药物与临床,2019,34(4):1065-1069.
王春霞,葛俊李,李芳,等.中药治疗溃疡性结肠炎作用及机制研究进展[J].中国实验方剂学杂志,2023,29(2):270-282.
OEHLERS S H,FLORES M V,HALL C J,et al.A whole animal chemical screen approach to identify modifiers of intestinal neutrophilic inflammation[J].FEBS J,2017,284(3):402-413.
LIU Y,YANG X,GAN J,et al.CB-Dock2: Improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting[J].Nucleic Acids Res,2022,50(W1):W159-W164.
MORALES FÉNERO C,AMARAL M A,XAVIER I K,et al.Short chain fatty acids (SCFAs) improves TNBS-induced colitis in zebrafish[J].Curr Res Immunol,2021,2:142-154.
ZELOVÁ H,HOŠEK J.TNF-α signalling and inflammation: Interactions between old acquaintances[J].Inflamm Res,2013,62(7):641-651.
BOZKURT A,CAKIR B,ERCAN F,et al.Anti-inflammatory effects of leptin and cholecystokinin on acetic acid-induced colitis in rats: Role of capsaicin-sensitive vagal afferent fibers[J].Regul Pept,2003,116(1/3):109-118.
VARGA G,BÁLINT A,BURGHARDT B,et al.Involvement of endogenous CCK and CCK1 receptors in colonic motor function[J].Br J Pharmacol,2004,141(8):1275-1284.
张晓雯,李凌宇,尚海,等.苦参碱及其类似物的结构修饰研究进展[J].中草药,2019,50(23):5892-5900.
徐萌,范恒.复方苦参汤治疗溃疡性结肠炎的临床和实验研究[C]//中国中西医结合学会基础理论专业委员会.第十四届中国中西医结合基础理论学术年会会议资料.中国中西医结合学会基础理论专业委员会,2018:9.
杜梦鸽,吕博,孟凌宇,等.基于网络药理学及实验验证探讨新疆紫草抗肝癌作用机制[J].中国实验方剂学杂志,2022,28(24):75-86.
刘霞,黄明春,张小琼,等.基于网络药理学和体外实验研究苔黑酚葡萄糖苷治疗骨质疏松的分子机制[J].中国实验方剂学杂志,2022,28(1):197-203.
张明晓,李化,陈娜,等.基于UPLC-Q-TOF-MS和GC-MS技术结合网络药理学探究辣木叶治疗便秘的作用机制[J].中国实验方剂学杂志,2022,28(22):182-188.
KEEVER K R,YAKUBENKO V P,HOOVER D B.Neuroimmune nexus in the pathophysiology and therapy of inflammatory disorders: Role of α7 nicotinic acetylcholine receptors[J].Pharmacol Res,2023,191:106758.
LI Z,HAO H,GAO Y,et al.Expression and localization analyses of the cholinergic anti-inflammatory pathway and α7nAchR in different tissues of rats with rheumatoid arthritis[J].Acta Histochem,2019,121(6):742-749.
YE Z,ZHU Y,TANG N,et al.α7 nicotinic acetylcholine receptor agonist GTS-21 attenuates DSS-induced intestinal colitis by improving intestinal mucosal barrier function[J].Mol Med,2022,28(1):59.
HOSUR V,LORING R H.α4β2 nicotinic receptors partially mediate anti-inflammatory effects through Janus kinase 2-signal transducer and activator of transcription 3 but not calcium or cAMP signaling[J].Mol Pharmacol,2011,79(1):167-174.
VAN DER ZANDEN E P,SNOEK S A,HEINSBROEK S E,et al.Vagus nerve activity augments intestinal macrophage phagocytosis via nicotinic acetylcholine receptor alpha4beta2[J].Gastroenterology,2009,137(3):1029-1039.
CERANTOLA S,FAGGIN S,CAPUTI V,et al.Small intestine neuromuscular dysfunction in a mouse model of dextran sulfate sodium-induced ileitis: Involvement of dopaminergic neurotransmission[J].Life Sci,2022,301:120562.
NASSER Y,KEENAN C M,MA A C,et al.Expression of a functional metabotropic glutamate receptor 5 on enteric glia is altered in states of inflammation[J].Glia,2007,55(8):859-872.
SINA C,LIPINSKI S,GAVRILOVA O,et al.Extracellular cathepsin K exerts antimicrobial activity and is protective against chronic intestinal inflammation in mice[J].Gut,2013,62(4):520-530.
YAO X,HUANG J,ZHONG H,et al.Targeting interleukin-6 in inflammatory autoimmune diseases and cancers[J].Pharmacol Ther,2014,141(2):125-139.
NEUBAUER K,BEDNARZ-MISA I,WALECKA-ZACHARSKA E,et al.Oversecretion and overexpression of nicotinamide phosphoribosyltransferase/Pre-B colony-enhancing factor/Visfatin in inflammatory bowel disease reflects the disease activity, severity of inflammatory response and hypoxia[J].Int J Mol Sci,2019,doi:10.3390/ijms20010166http://dx.doi.org/10.3390/ijms20010166.
MAO L,KITANI A,STROBER W,et al.The Role of NLRP3 and IL-1β in the pathogenesis of inflammatory bowel disease[J].Front Immunol,2018,9:2566.
0
浏览量
30
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构